Allianz’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.79M Hold
95,825
0.09% 134
2026
Q1
$8.17M Sell
95,825
-2,570
-3% -$229K 0.09% 129
2025
Q4
$7.78M Buy
98,395
+1,050
+1% +$82.3K 0.1% 124
2025
Q3
$7.78M Buy
97,345
+1,680
+2% +$143K 0.17% 109
2025
Q2
$8.7M Sell
95,665
-5,226
-5% -$477K 0.21% 97
2025
Q1
$9.45M Buy
100,891
+5,676
+6% +$508K 0.25% 82
2024
Q4
$8.64M Buy
95,215
+2,800
+3% +$267K 0.22% 92
2024
Q3
$9.59M Sell
92,415
-1,269
-1% -$129K 0.26% 81
2024
Q2
$9.09M Hold
93,684
0.27% 77
2024
Q1
$8.44M Buy
+93,684
New +$7.94M 0.27% 93

Other funds holding CL

Allianz's CL Position: Q2 2026 in Review

Allianz held its Colgate-Palmolive (CL) position steady in Q2 2026 at 95,825 shares worth $8.79M. The position accounts for 0.09% of the portfolio, ranked #134.

Allianz first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.59M in Q3 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Allianz held 95,825 shares of Colgate-Palmolive worth $8.79M as of Q2 2026.
  • Allianz left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.09% of Allianz's portfolio in Q2 2026, its #134 holding.
  • Allianz first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Colgate-Palmolive position peaked at $9.59M in Q3 2024.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.